Curis Inc

Biotechnology company · Lexington, Massachusetts, United States · Nasdaq: CRIS

Curis Inc is a biotechnology company headquartered in Lexington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker CRIS. It has reported private securities offerings to the US SEC, most recently $964,000 sold in a notice filed in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Curis at a glance

Typebiotechnology company

HeadquartersLexington, Massachusetts, United States

Stock listingNasdaq: CRIS

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1108205

What does Curis do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $964,000 sold (2012).

Frequently asked questions about Curis

Where is Curis headquartered?

Curis Inc is headquartered in Lexington, Massachusetts, United States.

What does Curis do?

Curis Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Curis a public company?

Yes. Curis Inc trades on Nasdaq under the ticker CRIS.

Similar companies

Agenus IncLexington, Massachusetts, United States
Voyager Therapeutics, Inc.Lexington, Massachusetts, United States
Biomedical Development CorpLexington, Kentucky, United States
Translate Bio, Inc.Lexington, Massachusetts, United States
LogicBio Therapeutics, Inc.Lexington, Massachusetts, United States
Oasis Pharmaceuticals, LLCLexington, Massachusetts, United States
LayerBio, Inc.Lexington, Massachusetts, United States
Hera Testing Laboratories, Inc.Lexington, Kentucky, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences